BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17343665)

  • 1. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning.
    Han SJ; Kim TS; Jeon SW; Jeong SJ; Yun M; Rhee Y; Kang ES; Cha BS; Lee EJ; Lee HC; Lim SK
    Int J Clin Pract; 2007 May; 61(5):802-9. PubMed ID: 17343665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of
    Cook GJR; Lovat E; Siddique M; Goh V; Ferner R; Warbey VS
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1845-1852. PubMed ID: 28589254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.
    Liu L; Lyu Z; Li H; Bai L; Wan Y; Li P
    BMC Med Imaging; 2023 Nov; 23(1):193. PubMed ID: 37986052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
    Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
    Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High 18F-Fluorodeoxyglucose Uptake in Adrenal Angiomyolipoma: Case Report and Review of Literature.
    Li W; Pang H; Cao Y; Guan L; Chen J
    Medicine (Baltimore); 2015 Jun; 94(22):e900. PubMed ID: 26039121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality imaging to distinguish between benign and malignant cardiac masses.
    Aghayev A; Cheezum MK; Steigner ML; Mousavi N; Padera R; Barac A; Kwong RY; Di Carli MF; Blankstein R
    J Nucl Cardiol; 2022 Aug; 29(4):1504-1517. PubMed ID: 34476778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 18F-fluorodeoxyglucose-positron emission tomography in the differential diagnosis of benign and malignant gynaecological tumours.
    Takagi H; Sakamoto J; Osaka Y; Shibata T; Fujita S; Sasagawa T
    J Med Imaging Radiat Oncol; 2018 Feb; ():. PubMed ID: 29399968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Death Confirmation by 18F-FDG PET/CT: A Case Series.
    Yousefi-Koma A; Sadegh-Beigee F; Ghorbani F; Mirbahaeddin K; Aghahosseini F; Alibeigi E; Jarrah N
    Exp Clin Transplant; 2023 Sep; 21(9):756-763. PubMed ID: 37885292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review.
    Gupta K; Jadhav R; Prasad R; Virmani S
    J Nucl Cardiol; 2020 Aug; 27(4):1296-1305. PubMed ID: 32016692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis.
    Dinnes J; Bancos I; Ferrante di Ruffano L; Chortis V; Davenport C; Bayliss S; Sahdev A; Guest P; Fassnacht M; Deeks JJ; Arlt W
    Eur J Endocrinol; 2016 Aug; 175(2):R51-64. PubMed ID: 27257145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of PET/CT in the central nervous system tumours].
    Szabó P
    Magy Onkol; 2023 Dec; 67(4):321-331. PubMed ID: 38109511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism.
    Ralli GP; Carter RD; McGowan DR; Cheng WC; Liu D; Teoh EJ; Patel N; Gleeson F; Harris AL; Lord SR; Buffa FM; Fenwick JD
    Breast Cancer Res; 2022 May; 24(1):34. PubMed ID: 35581637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of post-injection
    Lovat E; Siddique M; Goh V; Ferner RE; Cook GJR; Warbey VS
    EJNMMI Res; 2017 Dec; 7(1):35. PubMed ID: 28429332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A black adrenal adenoma with high FDG uptake on PET/CT scan in a patient with esophageal carcinoma: A case report.
    Matsumoto S; Hosoya Y; Lefor AK; Haruta H; Ui T; Kurashina K; Saito S; Ashizawa K; Sasaki T; Kitayama J; Sata N
    Int J Surg Case Rep; 2018; 44():118-121. PubMed ID: 29499515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose (FDG) Uptake in the Remnant Adrenal Gland Mimicking Tumor Recurrence in a Patient With Adrenocortical Carcinoma After Treatment With Mitotane.
    Ayala Torres JD; Noreña Rengifo B
    Cureus; 2024 Mar; 16(3):e55486. PubMed ID: 38571874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-human evaluation of [
    Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study.
    Ghafouri M; Duque L; Rodriguez LP; Philbrick KL; Savica R; Pazdernik VK; Port JD; Rummans TA; Singh B
    Schizophr Res; 2024 May; 267():138-140. PubMed ID: 38537394
    [No Abstract]   [Full Text] [Related]  

  • 18. SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report.
    Kambe A; Yamamoto Y; Hasegawa C; Kakiuchi A; Kojima D; Hino A; Horikawa A; Doiuchi T; Kurihara H
    Radiol Case Rep; 2024 Feb; 19(2):794-797. PubMed ID: 38111549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histoplasmosis in the differential diagnosis of hypermetabolic adrenal masses in
    Plaza López PJ; Parini G; Martinez Miralles E; Aguilar Puente Y
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Jul; ():. PubMed ID: 34305043
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.